- Home
- KNF vs AXSM Comparison
KNF vs AXSM Comparison
Compare KNF & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KNF | AXSM |
|---|---|---|
| Founded | 1917 | 2012 |
| Country | United States | United States |
| Employees | 4761 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 7.4B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | KNF | AXSM |
|---|---|---|
| Price | $73.28 | $152.16 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 20 |
| Target Price | $96.43 | ★ $176.00 |
| AVG Volume (30 Days) | 457.2K | ★ 464.4K |
| Earning Date | 02-12-2026 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.61 | N/A |
| Revenue | ★ $3,048,164,000.00 | $561,263,000.00 |
| Revenue This Year | $8.66 | $66.40 |
| Revenue Next Year | $5.84 | $56.13 |
| P/E Ratio | $28.22 | ★ N/A |
| Revenue Growth | 5.52 | ★ 65.83 |
| 52 Week Low | $58.72 | $75.56 |
| 52 Week High | $108.83 | $158.57 |
Technical Indicators
Market Signals| Indicator | KNF | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 49.55 | 58.25 |
| Support Level | $72.25 | $152.41 |
| Resistance Level | $74.23 | $158.56 |
| Average True Range (ATR) | 2.01 | 4.13 |
| MACD | -0.51 | 0.08 |
| Stochastic Oscillator | 16.47 | 55.41 |
Price Performance
Historical ComparisonAbout KNF Knife Riv Holding Co.
Knife River Holding Co is an aggregates-led construction materials and contracting services provider. Its segments include Pacific, Northwest, Mountain, North Central, South, and Energy Services. Each geographic segment offers a vertically integrated suite of products and services, including aggregates, ready-mix concrete, asphalt, and contracting services, while the Energy Services segment, which has locations throughout the company's geographic footprint, produces and supplies liquid asphalt and related services, for use in asphalt road construction, and is a supplier to some of the other segments.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.